Skip to main content
Saturday
November 30, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
SATURDAY,
NOVEMBER 30, 2024
Eli Lilly & Co
Bangladesh
Lilly and IABL collaborate to supply high-quality affordable insulin in Bangladesh
Coronavirus chronicle
US buys additional doses of Eli Lilly, Regeneron Covid-19 therapy
Coronavirus chronicle
Eli Lilly gets Indian emergency use nod for Covid-19 antibody drug combination
Coronavirus chronicle
Eli Lilly signs deals to boost supply of Covid-19 treatment in India
World+Biz
Lilly hit by staff accusations, FDA scrutiny at Covid drug factories
Coronavirus chronicle
Eli Lilly's arthritis drug fails to meet main goal of late-stage Covid-19 study
Coronavirus chronicle
Lilly-Vir's Covid-19 antibody combo reduced viral load in study
World+Biz
Insider alleges Eli Lilly blocked her efforts to sound alarms about US drug factory
Coronavirus chronicle
Eli Lilly's antibody combination receives FDA emergency use authorization for Covid-19
World+Biz
Eli Lilly CFO resigns after probe finds 'inappropriate communication' with employees
Coronavirus chronicle
Eli Lilly testing Covid-19 antibody treatment with Vir Biotech's drug
Coronavirus chronicle
Eli Lilly's antibody combination reduces risk of death from Covid-19 - study
Coronavirus chronicle
US allows emergency use of first Covid-19 antibody drug